Insider Trading25 Jun 2026, 01:12 pm
Akums Drugs Trading Window Closed for Q1 FY27 Results
AI Summary
Akums Drugs and Pharmaceuticals Ltd has announced the closure of its trading window for designated persons and their immediate relatives. This closure is in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015. The window will be shut from July 1st, 2026, and will reopen 48 hours after the declaration of the un-audited financial results for the quarter ending June 30th, 2026. The company will announce the date of the board meeting to approve these results in due course.
Key Highlights
- Trading window closed from July 1st, 2026.
- Closure is for designated persons and immediate relatives.
- Applies to Q1 FY27 un-audited financial results.
- Compliance with SEBI Insider Trading Regulations.
- Reopening 48 hours post financial results declaration.
Price Impact
More from AKUMS